Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 11.84%778.7M | 28.76%696.27M | 24.32%540.73M | 14.07%434.97M | 29.23%381.3M | 20.97%295.05M | 49.83%243.9M | 37.77%162.78M | 53.90%118.16M | 76.78M |
| Operating revenue | 11.84%778.7M | 28.76%696.27M | 24.32%540.73M | 14.07%434.97M | 29.23%381.3M | 20.97%295.05M | 49.83%243.9M | 37.77%162.78M | 53.90%118.16M | --76.78M |
| Cost of revenue | -3.22%107.7M | 33.86%111.29M | 30.66%83.14M | -1.06%63.63M | 12.10%64.31M | 22.87%57.37M | 64.37%46.7M | 41.88%28.41M | 73.92%20.02M | 11.51M |
| Gross profit | 14.70%671M | 27.84%584.98M | 23.23%457.59M | 17.14%371.33M | 33.37%316.99M | 20.52%237.67M | 46.76%197.21M | 36.93%134.38M | 50.37%98.13M | 65.26M |
| Operating expense | 14.55%407.1M | 36.72%355.39M | 8.06%259.94M | -0.93%240.56M | 12.55%242.83M | 34.41%215.76M | 51.46%160.52M | 40.05%105.98M | 22.45%75.67M | 61.8M |
| Selling and administrative expenses | 21.59%194.4M | 35.92%159.88M | 21.36%117.63M | -4.44%96.93M | -1.59%101.43M | 25.60%103.07M | 56.91%82.06M | 34.50%52.3M | -0.49%38.88M | --39.08M |
| -Selling and marketing expense | -14.60%51.6M | 31.72%60.42M | 33.37%45.87M | -8.99%34.4M | -11.72%37.79M | 28.20%42.81M | 85.16%33.39M | 40.29%18.03M | -24.55%12.86M | --17.04M |
| -General and administrative expense | 43.58%142.8M | 38.61%99.46M | 14.75%71.75M | -1.74%62.53M | 5.61%63.64M | 23.82%60.26M | 42.05%48.67M | 31.64%34.26M | 18.10%26.03M | --22.04M |
| Research and development costs | 8.59%185.3M | 38.75%170.64M | 25.11%122.99M | 1.50%98.3M | 22.14%96.85M | 34.52%79.29M | 50.35%58.95M | 43.28%39.21M | 20.42%27.36M | --22.72M |
| Depreciation amortization depletion | 9.80%27.3M | 28.64%24.86M | -57.36%19.33M | 1.58%45.33M | 33.37%44.63M | 71.53%33.46M | 34.78%19.51M | 53.54%14.47M | --9.43M | ---- |
| -Depreciation and amortization | 9.80%27.3M | 28.64%24.86M | -57.36%19.33M | 1.58%45.33M | 33.37%44.63M | 71.53%33.46M | 34.78%19.51M | 53.54%14.47M | --9.43M | ---- |
| Other operating expenses | --100K | ---- | ---- | ---- | -9.35%-75.13K | ---68.71K | ---- | ---- | ---- | ---- |
| Operating profit | 14.94%263.9M | 16.16%229.6M | 51.14%197.65M | 76.34%130.77M | 238.32%74.16M | -40.26%21.92M | 29.21%36.69M | 26.43%28.4M | 548.35%22.46M | 3.46M |
| Net non-operating interest income (expenses) | 63.38%-3.5M | -2,162.82%-9.56M | 124.95%463.35K | 39.71%-1.86M | 54.25%-3.08M | -151.64%-6.73M | -197.37%-2.68M | -270.95%-899.88K | 159.38%526.39K | -886.43K |
| Non-operating interest income | 118.66%3.8M | -66.34%1.74M | 436.10%5.16M | -8.44%963.07K | -50.62%1.05M | 60.84%2.13M | 24.25%1.32M | -46.26%1.07M | 111.62%1.98M | --937.21K |
| Non-operating interest expense | -41.29%6.2M | 170.41%10.56M | 102.76%3.91M | -34.27%1.93M | -61.58%2.93M | 91.97%7.63M | 111.76%3.97M | 48.33%1.88M | -13.67%1.26M | --1.47M |
| Total other finance cost | 49.61%1.1M | -7.44%735.24K | -11.18%794.32K | -25.61%894.28K | -2.80%1.2M | 4,428.27%1.24M | -69.52%27.31K | -53.35%89.62K | -46.41%192.11K | --358.46K |
| Other net income (expenses) | -50.13%100K | 101.10%200.52K | -2,840.17%-18.2M | 86.27%-619.12K | -105.91%-4.51M | 76.27M | -99.32%10.28K | 1.52M | ||
| Special income (charges) | ---- | ---- | -17.61%-728.12K | 89.95%-619.12K | ---6.16M | ---- | ---- | ---- | ---- | ---- |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | 17.61%728.12K | -89.95%619.12K | --6.16M | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -50.13%100K | 101.15%200.52K | ---17.47M | --0 | -97.83%1.65M | --76.27M | ---- | ---- | --1.57M | ---- |
| Income before tax | 17.42%287.8M | 23.02%245.1M | 14.75%199.24M | 56.14%173.63M | -10.98%111.2M | 133.38%124.92M | 27.49%53.53M | 23.71%41.98M | 1,216.50%33.94M | 2.58M |
| Income tax | 25.42%87.1M | 18.15%69.45M | 48.09%58.78M | 32.40%39.69M | 107.76%29.98M | -7.77%14.43M | 30.20%15.64M | 30.62%12.02M | 858.71%9.2M | 959.61K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 14.26%200.7M | 25.06%175.66M | 4.87%140.46M | 64.91%133.94M | -26.49%81.22M | 191.68%110.49M | 26.41%37.88M | 21.14%29.97M | 1,428.66%24.74M | 1.62M |
| Net income continuous operations | 14.26%200.7M | 25.06%175.66M | 4.87%140.46M | 64.91%133.94M | -26.49%81.22M | 191.68%110.49M | 26.41%37.88M | 21.14%29.97M | 1,428.66%24.74M | --1.62M |
| Noncontrolling interests | -491.09%-21.71K | -101.44%-3.67K | 255.13K | |||||||
| Net income attributable to the company | 14.26%200.7M | 25.06%175.66M | 4.87%140.46M | 64.91%133.94M | -26.49%81.22M | 191.51%110.49M | 26.47%37.9M | 22.41%29.97M | 1,412.90%24.48M | 1.62M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 14.26%200.7M | 25.06%175.66M | 4.87%140.46M | 64.91%133.94M | -26.49%81.22M | 191.51%110.49M | 26.47%37.9M | 22.41%29.97M | 1,412.90%24.48M | 1.62M |
| Diluted earnings per share | 13.81%0.604 | 23.73%0.5307 | 4.44%0.4289 | 64.14%0.4107 | -27.61%0.2502 | 178.82%0.3456 | 21.40%0.124 | 21.90%0.1021 | 1,302.09%0.0838 | 0.006 |
| Basic earnings per share | 13.77%0.6 | 23.33%0.5274 | 4.12%0.4276 | 64.64%0.4107 | -27.83%0.2494 | 178.82%0.3456 | 21.40%0.124 | 21.90%0.1021 | 1,302.09%0.0838 | 0.006 |
| Dividend per share | 23.61%0.1287 | 21.14%0.1042 | 35.94%0.086 | 95.62%0.0632 | 33.77%0.0323 | 7.12%0.0242 | 29.13%0.0226 | 128.36%0.0175 | 0.0077 | |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |